slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 22,441-22,470
Pages 885
Rows per page 30
Arc
22,441-22,470 of 26,550
18
The table uses checkmarks and crosses to indicate the presence or absence of specific therapeutic attributes across four different drug programs.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
19
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
20
Includes logos of partner/talent source institutions and photos of the team and lab facilities.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
08
The slide uses a process-oriented flow diagram to explain the therapeutic strategy.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
09
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
10
The slide highlights the mechanism of action and key benefits of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
19
The slide details a specific licensing deal with Qilu Pharmaceutical, including financial terms and geographic scope.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
20
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
21
The slide uses a three-column layout to explain the scientific basis and product advantages.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
22
Includes both in vitro (IFN-y fold increase) and in vivo (MC38 tumor model) efficacy data.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
23
The slide outlines a multi-part clinical trial structure with specific cohort sizes and dosing progression.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
24
Includes a footnote regarding the 3/21/2023 Court Scheduling Order.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
04
The slide uses a structured layout to present market data for three distinct cancer segments, including CAGR and projected market values.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Logic Chain1 hit
24
This is a standard TPP (Target Product Profile) table used in biotech/pharma pitch decks.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
25
The slide outlines a clinical development plan with specific milestones for 2025 and 2026, focusing on safety and efficacy cohorts.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
26
The slide contrasts the traditional CRO outsourcing model with a direct management model to justify cost efficiency.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
27
Standard corporate legal disclosure slide.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
28
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
01
Erasca | Investor Presentation Deck | 41 slidesErasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Setup1 hit
02
Erasca | Investor Presentation Deck | 41 slidesErasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Setup1 hit
03
The slide uses a hub-and-spoke diagram to connect the company brand to three core pillars: team, portfolio, and financials.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · SetupLoop · Cost Of Inaction1 hit
04
SAB stands for Scientific Advisory Board.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · SetupLoop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style chart to represent clinical trial progress.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · SetupLoop · Cost Of Inaction1 hit
06
The diagram illustrates a biological signaling pathway with specific nodes highlighted as targets for therapeutic intervention.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
07
The slide uses a matrix structure to map clinical assets to specific indications and trial names.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
08
The diagram shows the MAPK pathway inhibition. The patient population data is presented as a simple table.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
09
The slide uses a KINOMEscan visualization to show selectivity.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
10
The chart is a classic waterfall plot used in oncology to show best response per patient/model.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
11
The slide combines a biological pathway diagram with a clinical trial summary table to demonstrate clinical validation.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
12
The slide uses a side-by-side comparison of two market segments, each with a big number metric and supporting clinical/regulatory context.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit